XRCC5 and cancer: Taken together, the data demonstrate that the inhibition of PARP1 by inhibitors and by specific siRNAs blocks the interaction of the PARP1/Ku70/Ku80 complex with genes containing ALCDs, resulting in a repression of ALCD and subsequent inhibition of proliferation of cancer cells.